These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 27414616)

  • 1. China.
    Nurs Stand; 1988 Jan; 2(14):39. PubMed ID: 27414616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of perinatal hepatitis B transmission in Haimen City, China: Results of a community public health initiative.
    Evans AA; Cohen C; Huang P; Qian L; London WT; Block JM; Chen G
    Vaccine; 2015 Jun; 33(26):3010-5. PubMed ID: 25698491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. China's efforts to shed its title of "Leader in liver disease".
    Li X; Xu WF
    Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study on universal immunization of newborn infants in an area of hepatitis B virus and primary hepatocellular carcinoma prevalence with a low dose of hepatitis B vaccine.
    Sun TT; Chu YR; Ni ZQ; Lu JH; Huang F; Ni ZP; Pei XF; Yu ZI; Liu GT
    J Cell Physiol Suppl; 1986; 4():83-90. PubMed ID: 3018008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for hepatocellular carcinoma in Guangxi, People's Republic of China.
    Yeh FS; Mo CC; Yen RC
    Natl Cancer Inst Monogr; 1985 Dec; 69():47-8. PubMed ID: 3010122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen-positive and antigen-negative residents of Daxin, Qidong County, People's Republic of China.
    Wang JS; Qian GS; Zarba A; He X; Zhu YR; Zhang BC; Jacobson L; Gange SJ; Muñoz A; Kensler TW
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):253-61. PubMed ID: 8722216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The inception, achievements, and implications of the China GAVI Alliance Project on Hepatitis B Immunization.
    Kane MA; Hadler SC; Lee L; Shapiro CN; Cui F; Wang X; Kumar R
    Vaccine; 2013 Dec; 31 Suppl 9():J15-20. PubMed ID: 24331015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study.
    Sun Z; Zhu Y; Stjernsward J; Hilleman M; Collins R; Zhen Y; Hsia CC; Lu J; Huang F; Ni Z
    Cancer Detect Prev; 1991; 15(4):313-8. PubMed ID: 1665400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 R249S mutations, exposure to aflatoxin, and occurrence of hepatocellular carcinoma in a cohort of chronic hepatitis B virus carriers from Qidong, China.
    Szymañska K; Chen JG; Cui Y; Gong YY; Turner PC; Villar S; Wild CP; Parkin DM; Hainaut P
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1638-43. PubMed ID: 19366907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Suitability analysis of tolerance limit for aflatoxin M1 in foods and Chinese population dietary exposure to aflatoxin M1 from milk].
    Liang J; Song X; Zhu J; Li N; Xu H; Li F
    Wei Sheng Yan Jiu; 2013 Sep; 42(5):840-3, 867. PubMed ID: 24218897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modeling the transmission dynamics and control of hepatitis B virus in China.
    Zou L; Zhang W; Ruan S
    J Theor Biol; 2010 Jan; 262(2):330-8. PubMed ID: 19822154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aflatoxins and primary liver cancer--a population based case-control study].
    Zhang MD
    Zhonghua Yu Fang Yi Xue Za Zhi; 1992 Nov; 26(6):331-3. PubMed ID: 1303345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma and aflatoxin exposure in Zhuqing Village, Fusui County, People's Republic of China.
    Wang JS; Huang T; Su J; Liang F; Wei Z; Liang Y; Luo H; Kuang SY; Qian GS; Sun G; He X; Kensler TW; Groopman JD
    Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):143-6. PubMed ID: 11219772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People's Republic of China, and a meta-analysis of existing studies.
    Stern MC; Umbach DM; Yu MC; London SJ; Zhang ZQ; Taylor JA
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):617-25. PubMed ID: 11401911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress in hepatitis B prevention through universal infant vaccination--China, 1997-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 May; 56(18):441-5. PubMed ID: 17495790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis B virus infection and aflatoxin exposure in the development of primary liver cancer].
    Lu P; Kuang S; Wang J
    Zhonghua Yi Xue Za Zhi; 1998 May; 78(5):340-2. PubMed ID: 10923435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for liver cancer: results of a randomised controlled trial in Qidong, China.
    Chen JG; Parkin DM; Chen QG; Lu JH; Shen QJ; Zhang BC; Zhu YR
    J Med Screen; 2003; 10(4):204-9. PubMed ID: 14738659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and control of hepatitis B in China.
    Sun Z; Ming L; Zhu X; Lu J
    J Med Virol; 2002 Jul; 67(3):447-50. PubMed ID: 12116043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.
    Chang MH; You SL; Chen CJ; Liu CJ; Lee CM; Lin SM; Chu HC; Wu TC; Yang SS; Kuo HS; Chen DS;
    J Natl Cancer Inst; 2009 Oct; 101(19):1348-55. PubMed ID: 19759364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.